New therapeutic platforms for the treatment of epithelial and cutaneous lesions

Carla M. Caramella, Giuseppina Sandri, Silvia Rossi, Michela Mori, Maria Cristina Bonferoni, Franca Ferrari, Claudia Del Fante, Cesare Perotti

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

There are still so-called unmet needs in the treatment of epithelial and cutaneous lesions. Mucositis, ocular lesions, chronic skin wounds represent typical examples. These pathologies do not yet afford a satisfactory treatment. In particular chronic wounds represent a major health care burden, likely to increase as the population ages. Healing of epithelial and cutaneous lesions progresses through a complex cascade of events starting with the secretion in the local environment of a pool of growth factors, cytokines and proteins from the serum and degranulating platelets. Recently platelet lysate (PL), a hemoderivative obtained by platelet destruction by freeze-thawing of a platelet rich plasma (PRP) sample in the presence of an anticoagulant agent, has proved capable of promoting the healing of buccal and corneal lesions. Since the efficacy of growth factors (GFs) critically depends on the way they are made available to the injured tissue, the development of suitable therapeutic vehicles is of paramount importance to release GFs according to the repairing requirements. The present work focuses on the development and testing of few such formulations, in particular a mucoadhesive gel and an in situ gelling buccal spray for the treatment of oral mucositis, and a thermosensitive eye drop solution for corneal lesions. Besides technological characterization, the formulations have been preliminarily screened with an ELISA assay, a cell proliferation test and an in vitro wound healing test. Some formulations have been used in early clinical trials.

Original languageEnglish
Pages (from-to)18-31
Number of pages14
JournalCurrent Drug Delivery
Volume10
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Intercellular Signaling Peptides and Proteins
Skin
Blood Platelets
Cheek
Stomatitis
Mucositis
Platelet-Rich Plasma
Ophthalmic Solutions
Wounds and Injuries
Therapeutics
Wound Healing
Anticoagulants
Blood Proteins
Gels
Enzyme-Linked Immunosorbent Assay
Cell Proliferation
Clinical Trials
Pathology
Cytokines
Delivery of Health Care

Keywords

  • Buccal and corneal lesions
  • Cell culture models
  • Drug delivery systems
  • Platelet lysate
  • Wound healing

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Caramella, C. M., Sandri, G., Rossi, S., Mori, M., Bonferoni, M. C., Ferrari, F., ... Perotti, C. (2013). New therapeutic platforms for the treatment of epithelial and cutaneous lesions. Current Drug Delivery, 10(1), 18-31. https://doi.org/10.2174/1567201811310010005

New therapeutic platforms for the treatment of epithelial and cutaneous lesions. / Caramella, Carla M.; Sandri, Giuseppina; Rossi, Silvia; Mori, Michela; Bonferoni, Maria Cristina; Ferrari, Franca; Del Fante, Claudia; Perotti, Cesare.

In: Current Drug Delivery, Vol. 10, No. 1, 2013, p. 18-31.

Research output: Contribution to journalArticle

Caramella, Carla M. ; Sandri, Giuseppina ; Rossi, Silvia ; Mori, Michela ; Bonferoni, Maria Cristina ; Ferrari, Franca ; Del Fante, Claudia ; Perotti, Cesare. / New therapeutic platforms for the treatment of epithelial and cutaneous lesions. In: Current Drug Delivery. 2013 ; Vol. 10, No. 1. pp. 18-31.
@article{7e12db699e664f56bc13472455a75a36,
title = "New therapeutic platforms for the treatment of epithelial and cutaneous lesions",
abstract = "There are still so-called unmet needs in the treatment of epithelial and cutaneous lesions. Mucositis, ocular lesions, chronic skin wounds represent typical examples. These pathologies do not yet afford a satisfactory treatment. In particular chronic wounds represent a major health care burden, likely to increase as the population ages. Healing of epithelial and cutaneous lesions progresses through a complex cascade of events starting with the secretion in the local environment of a pool of growth factors, cytokines and proteins from the serum and degranulating platelets. Recently platelet lysate (PL), a hemoderivative obtained by platelet destruction by freeze-thawing of a platelet rich plasma (PRP) sample in the presence of an anticoagulant agent, has proved capable of promoting the healing of buccal and corneal lesions. Since the efficacy of growth factors (GFs) critically depends on the way they are made available to the injured tissue, the development of suitable therapeutic vehicles is of paramount importance to release GFs according to the repairing requirements. The present work focuses on the development and testing of few such formulations, in particular a mucoadhesive gel and an in situ gelling buccal spray for the treatment of oral mucositis, and a thermosensitive eye drop solution for corneal lesions. Besides technological characterization, the formulations have been preliminarily screened with an ELISA assay, a cell proliferation test and an in vitro wound healing test. Some formulations have been used in early clinical trials.",
keywords = "Buccal and corneal lesions, Cell culture models, Drug delivery systems, Platelet lysate, Wound healing",
author = "Caramella, {Carla M.} and Giuseppina Sandri and Silvia Rossi and Michela Mori and Bonferoni, {Maria Cristina} and Franca Ferrari and {Del Fante}, Claudia and Cesare Perotti",
year = "2013",
doi = "10.2174/1567201811310010005",
language = "English",
volume = "10",
pages = "18--31",
journal = "Current Drug Delivery",
issn = "1567-2018",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - New therapeutic platforms for the treatment of epithelial and cutaneous lesions

AU - Caramella, Carla M.

AU - Sandri, Giuseppina

AU - Rossi, Silvia

AU - Mori, Michela

AU - Bonferoni, Maria Cristina

AU - Ferrari, Franca

AU - Del Fante, Claudia

AU - Perotti, Cesare

PY - 2013

Y1 - 2013

N2 - There are still so-called unmet needs in the treatment of epithelial and cutaneous lesions. Mucositis, ocular lesions, chronic skin wounds represent typical examples. These pathologies do not yet afford a satisfactory treatment. In particular chronic wounds represent a major health care burden, likely to increase as the population ages. Healing of epithelial and cutaneous lesions progresses through a complex cascade of events starting with the secretion in the local environment of a pool of growth factors, cytokines and proteins from the serum and degranulating platelets. Recently platelet lysate (PL), a hemoderivative obtained by platelet destruction by freeze-thawing of a platelet rich plasma (PRP) sample in the presence of an anticoagulant agent, has proved capable of promoting the healing of buccal and corneal lesions. Since the efficacy of growth factors (GFs) critically depends on the way they are made available to the injured tissue, the development of suitable therapeutic vehicles is of paramount importance to release GFs according to the repairing requirements. The present work focuses on the development and testing of few such formulations, in particular a mucoadhesive gel and an in situ gelling buccal spray for the treatment of oral mucositis, and a thermosensitive eye drop solution for corneal lesions. Besides technological characterization, the formulations have been preliminarily screened with an ELISA assay, a cell proliferation test and an in vitro wound healing test. Some formulations have been used in early clinical trials.

AB - There are still so-called unmet needs in the treatment of epithelial and cutaneous lesions. Mucositis, ocular lesions, chronic skin wounds represent typical examples. These pathologies do not yet afford a satisfactory treatment. In particular chronic wounds represent a major health care burden, likely to increase as the population ages. Healing of epithelial and cutaneous lesions progresses through a complex cascade of events starting with the secretion in the local environment of a pool of growth factors, cytokines and proteins from the serum and degranulating platelets. Recently platelet lysate (PL), a hemoderivative obtained by platelet destruction by freeze-thawing of a platelet rich plasma (PRP) sample in the presence of an anticoagulant agent, has proved capable of promoting the healing of buccal and corneal lesions. Since the efficacy of growth factors (GFs) critically depends on the way they are made available to the injured tissue, the development of suitable therapeutic vehicles is of paramount importance to release GFs according to the repairing requirements. The present work focuses on the development and testing of few such formulations, in particular a mucoadhesive gel and an in situ gelling buccal spray for the treatment of oral mucositis, and a thermosensitive eye drop solution for corneal lesions. Besides technological characterization, the formulations have been preliminarily screened with an ELISA assay, a cell proliferation test and an in vitro wound healing test. Some formulations have been used in early clinical trials.

KW - Buccal and corneal lesions

KW - Cell culture models

KW - Drug delivery systems

KW - Platelet lysate

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=84875337574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875337574&partnerID=8YFLogxK

U2 - 10.2174/1567201811310010005

DO - 10.2174/1567201811310010005

M3 - Article

C2 - 22998040

AN - SCOPUS:84875337574

VL - 10

SP - 18

EP - 31

JO - Current Drug Delivery

JF - Current Drug Delivery

SN - 1567-2018

IS - 1

ER -